Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Phase III BTOG2 trial assesses combination therapies for advanced lung cancer

Dec. 30, 2011

New suicide gene strategy shows promise as safety switch for cell therapy

Dec. 30, 2011

U.S. study describes new radiosensitizer's mode of action

Dec. 30, 2011

Progen to switch formulation of potential best-in-class heparanase inhibitor

Dec. 29, 2011

Marina Biotech and Mirna Therapeutics enter agreement for microRNA-based drugs

Dec. 29, 2011

BiTE antibody shows promise to treat diffuse large B-cell lymphoma

Dec. 29, 2011

New European approval for Avastin

Dec. 28, 2011

Roche submits MAA for vismodegib

Dec. 28, 2011

AVEO Pharmaceuticals begins enrollment in tivozanib trial

Dec. 28, 2011

Intellikine patents new protein kinase inhibitors

Dec. 28, 2011

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 28, 2026.
Detecting the invisible: minimal residual disease at AACR 2026
BioWorld Science
Minimal residual disease (MRD) has become a central concept in modern oncology, reshaping how clinicians evaluate response, relapse risk and treatment precision....
News in brief
BioWorld Asia
BioWorld Asia briefs for April 28, 2026
Sichuan Kelun Pharmaceutical Research Institute discovers GPR6 inverse agonists
BioWorld Science
Sichuan Kelun Pharmaceutical Research Institute Co. Ltd. has identified G protein-coupled receptor 6 (GPR6) inverse agonists reported to be useful for the...
Grace Therapeutics hits CRL setback with GTx-104 despite positive trial
BioWorld
Grace Therapeutics Inc.’s hopes of becoming the first company in decades to update the standard of care in aneurysmal subarachnoid hemorrhage were delayed after...